chr17-10525340-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 4P and 3B. PM1PM2BP4_ModerateBS1_Supporting
The NM_017534.6(MYH2):c.4546T>A(p.Ser1516Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000223 in 1,614,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_017534.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH2 | NM_017534.6 | c.4546T>A | p.Ser1516Thr | missense_variant | Exon 33 of 40 | ENST00000245503.10 | NP_060004.3 | |
MYH2 | NM_001100112.2 | c.4546T>A | p.Ser1516Thr | missense_variant | Exon 33 of 40 | NP_001093582.1 | ||
MYHAS | NR_125367.1 | n.168-42197A>T | intron_variant | Intron 2 of 10 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000115 AC: 29AN: 251226Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135770
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461866Hom.: 0 Cov.: 33 AF XY: 0.0000275 AC XY: 20AN XY: 727232
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152168Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74334
ClinVar
Submissions by phenotype
Myopathy, proximal, and ophthalmoplegia Uncertain:2
- -
This sequence change replaces serine, which is neutral and polar, with threonine, which is neutral and polar, at codon 1516 of the MYH2 protein (p.Ser1516Thr). This variant is present in population databases (rs778405343, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with MYH2-related conditions. ClinVar contains an entry for this variant (Variation ID: 534349). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt MYH2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.4546T>A (p.S1516T) alteration is located in exon 33 (coding exon 31) of the MYH2 gene. This alteration results from a T to A substitution at nucleotide position 4546, causing the serine (S) at amino acid position 1516 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at